PRESS RELEASE published on 08/05/2025 at 11:09, 8 months 4 days ago Elmos Semiconductor SE welcomes new apprentices and dual students to its Dortmund site Elmos Semiconductor SE welcomes new apprentices and dual students to its Dortmund site, offering various apprenticeships and study programs. The company focuses on structured training and personal development Elmos Semiconductor SE Personal Development Training Programs Apprenticeships Dual Students
PRESS RELEASE published on 08/05/2025 at 11:06, 8 months 4 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* JPMorgan Chase & Co. holds 4.69% voting rights in Dalata Hotel Group PLC as of 31st July 2025 through direct and indirect holdings, according to TR-1 notification Voting Rights TR-1 Notification Dalata Hotel Group Plc Financial Instruments JPMorgan Chase & Co.
PRESS RELEASE published on 08/05/2025 at 10:53, 8 months 4 days ago EQS-Adhoc: fox e-mobility AG: trading resumption in the newly converted fox e-mobility AG shares Trading in newly converted fox e-mobility AG shares to resume following 100:1 stock split on August 5, 2025 Share Capital Fox E-mobility AG Trading Resumption Stock Split Düsseldorf Stock Exchange
REGULATED PRESS RELEASE published on 08/05/2025 at 10:43, 8 months 4 days ago Disclosure of Share Capital and Voting Rights as of July 31, 2025 Edenred discloses share capital and voting rights as of July 31, 2025, in compliance with French regulations. Details available on edenred.com Edenred Share Capital Voting Rights French Regulations
PRESS RELEASE published on 08/05/2025 at 10:37, 8 months 4 days ago Cooperation between Volksbanken in the Cloppenburg district and PNE AG bears first fruit: 86.4 MW wind farm cooperation project in Lower Saxony receives permit Cooperation between Volksbanken and PNE AG results in 86.4 MW wind farm project in Lower Saxony receiving permit, combining community model with institutional participation PNE AG Coopération Wind Farm Volksbanken Permit
PRESS RELEASE published on 08/05/2025 at 09:57, 8 months 4 days ago Vantiva - Notification of availability of the financial interim report for the half-year ended June 30, 2025 Vantiva announces availability of half-year financial interim report as of June 30, 2025 in compliance with AMF regulations. Report accessible on www.vantiva.com/en Sustainability AMF Regulations Connectivity Vantiva Financial Interim Report
PRESS RELEASE published on 08/05/2025 at 09:55, 8 months 4 days ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 8 months 4 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
PRESS RELEASE published on 08/05/2025 at 09:30, 8 months 4 days ago PFISTERER receives building permit for high-voltage laboratory – Milestone in entry into HVDC market PFISTERER receives building permit for high-voltage laboratory, a strategic milestone in entering HVDC market. Investment of 30 million euros to develop future-proof cable accessories Technology Leader Energy Technology PFISTERER High-voltage Laboratory HVDC Market
PRESS RELEASE published on 08/05/2025 at 09:05, 8 months 4 days ago BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment BioNxt Solutions Inc. makes significant progress in global patent portfolio with EPO and EAPO confirming acceptance of core claims for sublingual Cladribine thin-film formulation. Focus on innovation in MS treatment BioNxt Solutions Inc. Patent Portfolio Cladribine EPO EAPO
Published on 04/10/2026 at 02:15, 5 hours 2 minutes ago Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Published on 04/10/2026 at 01:05, 6 hours 12 minutes ago Pathfinder Ventures Inc. Announces Tranche Closing of Financing and Extension of Private Placement
Published on 04/10/2026 at 00:00, 7 hours 17 minutes ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/09/2026 at 23:15, 8 hours 2 minutes ago Digi Power X Enters into Amended and Restated Sales Agreement
Published on 04/10/2026 at 07:00, 17 minutes ago Lindt & Sprüngli completes buyback of own shares and participation certificates ahead of schedule and launches new buyback program in May
Published on 04/09/2026 at 22:00, 9 hours 17 minutes ago Invitation - First Quarter 2026 Trading Update Conference Call
Published on 04/09/2026 at 21:01, 10 hours 16 minutes ago GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 20:03, 11 hours 14 minutes ago Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:35, 12 hours 42 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 15 hours 19 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 1 day ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 13 hours ago Publication of the 2025 Universal Registration Document